Fundraising Fox
/People
Sign in

Johnathan Matlock

Investor

Former Advisor at Ascension Ventures

London

Writes $100K – $5M checks · typically $1.5M

Find your path to Johnathan

363 people in our graph can introduce you to Johnathan.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Andy Summerfield to introduce you to Johnathan

You →Andy · together at Elbow Beach Capital (2022–2026) →Johnathan

Ask Jamie Chen to introduce you to Johnathan

You →Jamie · together at Elbow Beach Capital →Johnathan

Ask Sam Okafor to introduce you to Johnathan

You →Sam · 4 people · together at Ascension →Johnathan

Sign up to find every way you can get introduced to Johnathan

  • Your email: the people you already email who know Johnathan
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Johnathan
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Johnathan Matlock is Co-Founder and General Partner at Empirical Ventures, a UK-based DeepTech fund with £20m in assets under management and 25 portfolio companies. He holds a PhD in Organic Chemistry and brings 15 years of experience across science, entrepreneurship, and investment, including a prior role as employee #7 at Ziylo, which was acquired by Novo Nordisk for £623m in 2018. Matlock is a Chartered Chemist with 11 published papers and four patents, and has built an additional angel portfolio of 50 companies across DeepTech and Life Sciences.

Experience

  1. Empirical VenturesCo-Foundercurrent2024 — presentUnited Kingdom
  2. QV BioelectronicsBoard Observer and Advisorcurrent2022 — presentCheshire, England, United Kingdom
  3. CheMastery Group LtdBoard Observer and Advisorcurrent2022 — presentLondon, England, United Kingdom
  4. Elbow Beach CapitalAdvisory Board Membercurrent2022 — presentLondon, England, United Kingdom
  5. GenomeKeyBoard Observer and Advisorcurrent2021 — presentBristol, England, United Kingdom
  6. ARGONAUTE RNA LIMITEDNon Executive Directorcurrent2020 — presentBristol, England, United Kingdom
  7. GlaiaNon Executive Director2022 — 2024Bristol, England, United Kingdom
  8. Science Angel SyndicateCo-Founder2021 — 2024United Kingdom
  9. Ascension VenturesAdvisor2020 — 2023
  10. WASE LIMITEDBoard Observer and Advisor2021 — 2023Bristol, England, United Kingdom
  11. AnaphiteBoard Observer and Advisor2019 — 2022Bristol, England, United Kingdom
  12. Signum-Health LtdBoard Observer and Advisor2019 — 2021Caerphilly, Caerphilly, United Kingdom
  13. ZentraxaBoard Observer and Advisor2019 — 2020Bristol, England, United Kingdom
  14. CarbometricsSenior Scientist2018 — 2019Bristol, United Kingdom
  15. ZiyloSenior Scientist2017 — 2018Bristol, United Kingdom
  16. University of BristolPostdoctoral Research Assistant (Prof. Jonathan Clayden)2015 — 2017Bristol, United Kingdom
  17. University of BristolPostdoctoral Research Assistant (Prof. Varinder Aggarwal)2015Bristol, United Kingdom
  18. GSKCASE Placement2013Stevenage, United Kingdom
  19. Roche PharmaceuticalsInternship Student Medicinal Chemistry (RICH)2009 — 2010Basel Area, Switzerland

Skills & more

Languages English

From Johnathan's professional profile.

Investments

Investor

Argonaute RNABoobybiomeCaudal EnergyChemasteryEnsilitechHalo TherapeuticsHealome TherapeuticsMintneuroNeuronosticsOpteraOssTecOutSeeQV BioelectronicsZentraxa

Per curated public sources.

Network3

Bill LiaoScout
General Partner at SOSV
Ed PhillipsScout
Managing Director, Global at Future Planet Capital
Emma SteeleScout
Partner at Ascension

Investors connected to Johnathan in public investor directories — a warm-intro map.

Frequently asked questions

Who is Johnathan Matlock?
Johnathan Matlock is Co-Founder and General Partner at Empirical Ventures, a UK-based DeepTech fund with £20m in assets under management and 25 portfolio companies. He holds a PhD in Organic Chemistry and brings 15 years of experience across science, entrepreneurship, and investment, including a prior role as employee #7 at Ziylo, which was acquired by Novo Nordisk for £623m in 2018. Matlock is a Chartered Chemist with 11 published papers and four patents, and has built an additional angel portfolio of 50 companies across DeepTech and Life Sciences.
What check size does Johnathan Matlock write?
Johnathan Matlock typically writes checks of $100K – $5M.
What companies has Johnathan Matlock invested in?
Investments tracked here include Argonaute RNA, Boobybiome, Caudal Energy, Chemastery, Ensilitech, Halo Therapeutics, Healome Therapeutics, Mintneuro, Neuronostics, Optera, OssTec, OutSee, and 2 more.
Where did Johnathan Matlock go to school?
Johnathan Matlock studied at University of Bristol (Doctor of Philosophy (PhD), Organic Chemistry); University of York (Master of Chemistry, Chemistry); William Bradford Community College.

Same school

Shared employers